{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:14:47Z","timestamp":1784758487429,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.japh.2025.102360","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T21:23:26Z","timestamp":1739654606000},"page":"102360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mixed-methods systematic review of pharmacist-administered injectable contraception: Insights from patients, pharmacists, and other health care professionals"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2861-3074","authenticated-orcid":false,"given":"Nicole E.","family":"Cieri-Hutcherson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1630-874X","authenticated-orcid":false,"given":"Timothy C.","family":"Hutcherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1022-4214","authenticated-orcid":false,"given":"Elizabeth M.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8756-0714","authenticated-orcid":false,"given":"John","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0251-0295","authenticated-orcid":false,"given":"Nicholas D.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2025.102360_bib1","series-title":"World Family Planning 2022: Meeting the Changing Needs for Family Planning: Contraceptive Use by Age and Method","year":"2022"},{"issue":"2","key":"10.1016\/j.japh.2025.102360_bib2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2307\/2991665","article-title":"Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation","volume":"30","author":"Rosenberg","year":"1998","journal-title":"Fam Plan Perspect"},{"key":"10.1016\/j.japh.2025.102360_bib3","series-title":"Depo-Provera (Medroxyprogesterone Acetate) Prescribing Information","year":"1992"},{"key":"10.1016\/j.japh.2025.102360_bib4","series-title":"Depo-subQ Provera 104 (Medroxyprogesterone Acetate) Prescribing Information","year":"2005"},{"key":"10.1016\/j.japh.2025.102360_bib5","series-title":"UpToDate Lexidrug","year":"2024"},{"issue":"4","key":"10.1016\/j.japh.2025.102360_bib6","article-title":"Combination injectable contraceptives for contraception","volume":"2008","author":"Gallo","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.japh.2025.102360_bib8","series-title":"Guttmacher Policy Review. Pharmacist-Prescribed Contraceptives","year":"2023"},{"issue":"RR-3","key":"10.1016\/j.japh.2025.102360_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7303a1","article-title":"U.S. Selected practice recommendations for contraceptive use, 2024","volume":"73","author":"Curtis","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.japh.2025.102360_bib10","series-title":"Task Sharing to Improve Access to Family Planning\/contraception","year":"2018"},{"key":"10.1016\/j.japh.2025.102360_bib11","series-title":"Pfizer's Sayana Press Becomes First Injectable Contraceptive in the United Kingdom Available for Administration by Self-Injection","year":"2015"},{"issue":"6","key":"10.1016\/j.japh.2025.102360_bib12","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.contraception.2020.09.001","article-title":"An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA)","volume":"102","author":"Katz","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.japh.2025.102360_bib13","series-title":"Contraceptive Deserts","year":"2024"},{"key":"10.1016\/j.japh.2025.102360_bib7","series-title":"Pharmacist Immunization Authority","year":"2023"},{"key":"10.1016\/j.japh.2025.102360_bib14","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.japh.2025.102360_bib15","article-title":"RoB 2: a revised tool for assessing risk of bias in randomized trials","volume":"366","author":"Higgins","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.japh.2025.102360_bib16","article-title":"Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)","volume":"6","author":"Downes","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.japh.2025.102360_bib17","series-title":"GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations","year":"2013"},{"issue":"suppl 1","key":"10.1016\/j.japh.2025.102360_bib18","first-page":"1","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings","volume":"13","author":"Lewin","year":"2018","journal-title":"Implement Sci"},{"issue":"1","key":"10.1016\/j.japh.2025.102360_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jrsm.1582","article-title":"A framework for synthesizing intervention evidence from multiple sources into a single certainty of evidence rating: methodological developments from a US National Academies of Sciences, Engineering, and Medicine Committee","volume":"14","author":"Calonge","year":"2023","journal-title":"Res Synth Methods"},{"issue":"4","key":"10.1016\/j.japh.2025.102360_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1331\/JAPhA.2007.06112","article-title":"Pharmacy and clinic partnerships to expand access to injectable contraceptives","volume":"47","author":"Monastersky Maderas","year":"2007","journal-title":"J Am Pharm Assoc"},{"issue":"2","key":"10.1016\/j.japh.2025.102360_bib21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.contraception.2010.01.013","article-title":"Pharmacist-administered subcutaneous depot medroxyprogesterone acetate: a pilot randomized controlled trial","volume":"82","author":"Picardo","year":"2010","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.japh.2025.102360_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/ijpp.12249","article-title":"Evaluating the attractiveness of the availability of injectable progestogen contraceptives at the community pharmacy setting in the United Kingdom","volume":"24","author":"Heller","year":"2016","journal-title":"Int J Pharm Pract"},{"issue":"5","key":"10.1016\/j.japh.2025.102360_bib23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/13625187.2017.1357808","article-title":"The feasibility of contraceptive injections at the community pharmacy","volume":"22","author":"Heller","year":"2017","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"4","key":"10.1016\/j.japh.2025.102360_bib24","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.japh.2022.01.018","article-title":"Community pharmacists' provision of sexual and reproductive health services: a cross-sectional study in Alberta, Canada","volume":"62","author":"Navarrete","year":"2022","journal-title":"J Am Pharm Assoc"},{"issue":"2","key":"10.1016\/j.japh.2025.102360_bib25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.japh.2022.12.002","article-title":"A survey of Alberta pharmacists' actions and opinions in regard to administering vaccines and medications by injection","volume":"63","author":"Khan","year":"2023","journal-title":"J Am Pharm Assoc"},{"issue":"5","key":"10.1016\/j.japh.2025.102360_bib26","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.healthpol.2015.02.007","article-title":"From \u201cretailers\u201d to health care providers: transforming the role of community pharmacists in chronic disease management","volume":"119","author":"Mossialos","year":"2015","journal-title":"Health Policy"},{"key":"10.1016\/j.japh.2025.102360_bib27","article-title":"Community pharmacists on the frontline in the chronic disease management: the need for primary healthcare policy reforms in low and middle income countries","volume":"2","author":"Okoro","year":"2021","journal-title":"Explor Res Clin Soc Pharm"},{"key":"10.1016\/j.japh.2025.102360_bib28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12913-023-09222-z","article-title":"Understanding of healthcare professionals towards the roles and competencies of clinical pharmacists in South Africa","volume":"23","author":"Crafford","year":"2023","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"10.1016\/j.japh.2025.102360_bib29","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/GCO.0000000000000329","article-title":"Injectable contraception: updates and innovation","volume":"28","author":"Schivone","year":"2016","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.japh.2025.102360_bib30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0010-7824(96)00085-6","article-title":"Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception","volume":"53","author":"Lei","year":"1996","journal-title":"Contraception"},{"issue":"148","key":"10.1016\/j.japh.2025.102360_bib31","first-page":"1","article-title":"Reasons for nonuse of contraceptive methods by women with demand for contraception not satisfied: an assessment of low and middle-income countries using demographic health surveys","volume":"16","author":"Moreira","year":"2019","journal-title":"Reprod Health"},{"issue":"5","key":"10.1016\/j.japh.2025.102360_bib32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/17151635221115183","article-title":"Identifying vaccination deserts: the availability and distribution of pharmacists with authorization to administer injections in Ontario","volume":"155","author":"Houle","year":"2022","journal-title":"Can Pharm J"},{"key":"10.1016\/j.japh.2025.102360_bib35","series-title":"Self-Administration of Injectable Contraception","year":"2020"},{"issue":"8","key":"10.1016\/j.japh.2025.102360_bib36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5688\/aj7408141","article-title":"Presenting and evaluating qualitative research","volume":"74","author":"Anderson","year":"2010","journal-title":"Am J Pharm Educ"},{"issue":"10","key":"10.1016\/j.japh.2025.102360_bib37","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2471\/BLT.07.040162","article-title":"Contraceptive injections by community health workers in Uganda: a nonrandomized community trial","volume":"85","author":"Stanback","year":"2007","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.japh.2025.102360_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1363\/3702411","article-title":"Injected with controversy: sales and administration of injectable contraceptives in drug shops in Uganda","volume":"37","author":"Stanback","year":"2011","journal-title":"Int Perspect Sex Reprod Health"},{"issue":"4","key":"10.1016\/j.japh.2025.102360_bib39","doi-asserted-by":"crossref","first-page":"472","DOI":"10.9745\/GHSP-D-14-00085","article-title":"Getting closer to people: family planning provision by drug shops in Uganda","volume":"2","author":"Akol","year":"2014","journal-title":"Glob Health Sci Pract"},{"issue":"53","key":"10.1016\/j.japh.2025.102360_bib40","first-page":"e25","article-title":"Lessons from a geospatial analysis of depot medroxyprogesterone acetate sales by licensed chemical sellers in Ghana","volume":"130","author":"Shelus","year":"2015","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.japh.2025.102360_bib41","first-page":"79","article-title":"Delivery and utilization of injectable contraceptive services in rural Nigeria: learning from the perspectives of patent medicine vendors and women of reproductive age","volume":"19","author":"Ajuwon","year":"2016","journal-title":"Afr J Biomed Res"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125000391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125000391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T01:37:15Z","timestamp":1747791435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319125000391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1544319125000391"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2025.102360","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mixed-methods systematic review of pharmacist-administered injectable contraception: Insights from patients, pharmacists, and other health care professionals","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2025.102360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102360"}}